Metastatic Colorectal Cancer in the Era of Personalized Medicine: A More Tailored Approach to Systemic Therapy
Colorectal cancer is the second most common malignancy diagnosed in Canada. Despite declining incidence and mortality rates in recent years, there is still a significant number of cases that are metastatic at presentation. Fluoropyrimidine-based chemotherapy was the backbone of colorectal cancer tre...
Saved in:
| Main Authors: | Irene S. Yu, Winson Y. Cheung |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2018-01-01
|
| Series: | Canadian Journal of Gastroenterology and Hepatology |
| Online Access: | http://dx.doi.org/10.1155/2018/9450754 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Integrating Systemic Therapies into the Multimodality Treatment of Resectable Colorectal Liver Metastases
by: Omar Abdel-Rahman, et al.
Published: (2018-01-01) -
Tailoring traditional Chinese medicine in cancer therapy
by: Shuiquan Li, et al.
Published: (2025-01-01) -
Main aspects of personalized approach to the treatment of patients with chemotherapy resistant metastatic colorectal cancer
by: O. Yu. Stukalova, et al.
Published: (2024-12-01) -
Pharmacoeconomic evaluation of the effectiveness of therapy for metastatic colorectal cancer
by: Yu. Yu. Petukhova, et al.
Published: (2021-10-01) -
Immune checkpoint inhibitors in metastatic colorectal cancer therapy (a review)
by: P. P. Sorochan, et al.
Published: (2022-07-01)